To expand our business, we're partnering on promising products that complement our in-house portfolio and will help us achieve long-term growth. Our strategy involves acquiring new products and product candidates, and companies that will drive our portfolio in key therapeutic areas. Our decades-long history of effective collaboration exemplifies our ability to license products in and out of Daiichi Sankyo, develop and maintain valuable partnerships, and successfully complete mergers and acquisitions.